Literature DB >> 28550186

Mutations in the 3' untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia.

Tamara Bittolo1, Federico Pozzo1, Riccardo Bomben1, Tiziana D'Agaro1, Vanessa Bravin1, Pietro Bulian1, Francesca Maria Rossi1, Antonella Zucchetto1, Massimo Degan1, Paolo Macor2, Giovanni D'Arena3, Annalisa Chiarenza4, Francesco Zaja5, Gabriele Pozzato6, Francesco Di Raimondo4, Davide Rossi7, Gianluca Gaidano8, Giovanni Del Poeta9, Valter Gattei10, Michele Dal Bo10.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28550186      PMCID: PMC6643732          DOI: 10.3324/haematol.2016.162594

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.

Authors:  Stephan Stilgenbauer; Andrea Schnaiter; Peter Paschka; Thorsten Zenz; Marianna Rossi; Konstanze Döhner; Andreas Bühler; Sebastian Böttcher; Matthias Ritgen; Michael Kneba; Dirk Winkler; Eugen Tausch; Patrick Hoth; Jennifer Edelmann; Daniel Mertens; Lars Bullinger; Manuela Bergmann; Sabrina Kless; Silja Mack; Ulrich Jäger; Nancy Patten; Lin Wu; Michael K Wenger; Günter Fingerle-Rowson; Peter Lichter; Mario Cazzola; Clemens M Wendtner; Anna M Fink; Kirsten Fischer; Raymonde Busch; Michael Hallek; Hartmut Döhner
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

Review 2.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

3.  NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

Authors:  F Pozzo; T Bittolo; F Arruga; P Bulian; P Macor; E Tissino; B Gizdic; F M Rossi; R Bomben; A Zucchetto; D Benedetti; M Degan; G D'Arena; A Chiarenza; F Zaja; G Pozzato; D Rossi; G Gaidano; G Del Poeta; S Deaglio; V Gattei; M Dal Bo
Journal:  Leukemia       Date:  2015-07-13       Impact factor: 11.528

4.  CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.

Authors:  M Dal Bo; P Bulian; R Bomben; A Zucchetto; F M Rossi; F Pozzo; E Tissino; D Benedetti; T Bittolo; P Nanni; I Cattarossi; E Zaina; H Chivilò; M Degan; F Zaja; G Pozzato; A Chiarenza; F Di Raimondo; M I Del Principe; G Del Poeta; D Rossi; G Gaidano; V Gattei
Journal:  Leukemia       Date:  2016-04-25       Impact factor: 11.528

5.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

6.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

7.  Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.

Authors:  Constantine S Tam; Joselle Otero-Palacios; Lynne V Abruzzo; Jeffrey L Jorgensen; Alessandra Ferrajoli; William G Wierda; Susan Lerner; Susan O'Brien; Michael J Keating
Journal:  Br J Haematol       Date:  2008-04       Impact factor: 6.998

8.  Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.

Authors:  Ferran Nadeu; Julio Delgado; Cristina Royo; Tycho Baumann; Tatjana Stankovic; Magda Pinyol; Pedro Jares; Alba Navarro; David Martín-García; Sílvia Beà; Itziar Salaverria; Ceri Oldreive; Marta Aymerich; Helena Suárez-Cisneros; Maria Rozman; Neus Villamor; Dolors Colomer; Armando López-Guillermo; Marcos González; Miguel Alcoceba; Maria José Terol; Enrique Colado; Xose S Puente; Carlos López-Otín; Anna Enjuanes; Elías Campo
Journal:  Blood       Date:  2016-02-02       Impact factor: 22.113

9.  The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.

Authors:  E Matutes; K Owusu-Ankomah; R Morilla; J Garcia Marco; A Houlihan; T H Que; D Catovsky
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528

10.  Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

Authors:  Giulia Fabbri; Silvia Rasi; Davide Rossi; Vladimir Trifonov; Hossein Khiabanian; Jing Ma; Adina Grunn; Marco Fangazio; Daniela Capello; Sara Monti; Stefania Cresta; Ernesto Gargiulo; Francesco Forconi; Anna Guarini; Luca Arcaini; Marco Paulli; Luca Laurenti; Luigi M Larocca; Roberto Marasca; Valter Gattei; David Oscier; Francesco Bertoni; Charles G Mullighan; Robin Foá; Laura Pasqualucci; Raul Rabadan; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  J Exp Med       Date:  2011-06-13       Impact factor: 14.307

View more
  9 in total

1.  NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.

Authors:  D Benedetti; E Tissino; F Pozzo; T Bittolo; C Caldana; C Perini; D Martorelli; V Bravin; T D'Agaro; F M Rossi; R Bomben; E Santinelli; F Zaja; G Pozzato; A Chiarenza; F Di Raimondo; G Del Poeta; D Rossi; G Gaidano; M Dal Bo; V Gattei; A Zucchetto
Journal:  Leukemia       Date:  2017-09-22       Impact factor: 11.528

Review 2.  Prognostic Factors in the Era of Targeted Therapies in CLL.

Authors:  Prajwal Boddu; Alessandra Ferrajoli
Journal:  Curr Hematol Malig Rep       Date:  2018-04       Impact factor: 3.952

3.  NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases.

Authors:  Yixin Zou; Lei Fan; Yi Xia; Yi Miao; Wei Wu; Lei Cao; Jiazhu Wu; Huayuan Zhu; Chun Qiao; Li Wang; Wei Xu; Jianyong Li
Journal:  Cancer Med       Date:  2018-03-23       Impact factor: 4.452

Review 4.  Overview of non-coding mutations in chronic lymphocytic leukemia.

Authors:  Valeria Spina; Davide Rossi
Journal:  Mol Oncol       Date:  2019-01-04       Impact factor: 6.603

Review 5.  Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond.

Authors:  Federico Pozzo; Tamara Bittolo; Erika Tissino; Antonella Zucchetto; Riccardo Bomben; Laura Polcik; Svenja Dannewitz Prosseda; Tanja Nicole Hartmann; Valter Gattei
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575

6.  CD20 Expression as a Possible Novel Prognostic Marker in CLL: Application of EuroFlow Standardization Technique and Normalization Procedures in Flow Cytometric Expression Analysis.

Authors:  Anke Schilhabel; Peter Jonas Walter; Paula Cramer; Julia von Tresckow; Saskia Kohlscheen; Monika Szczepanowski; Anna Laqua; Kirsten Fischer; Barbara Eichhorst; Sebastian Böttcher; Christof Schneider; Eugen Tausch; Monika Brüggemann; Michael Kneba; Michael Hallek; Matthias Ritgen
Journal:  Cancers (Basel)       Date:  2022-10-07       Impact factor: 6.575

Review 7.  NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.

Authors:  Emanuela Rosati; Stefano Baldoni; Filomena De Falco; Beatrice Del Papa; Erica Dorillo; Chiara Rompietti; Elisa Albi; Franca Falzetti; Mauro Di Ianni; Paolo Sportoletti
Journal:  Front Oncol       Date:  2018-06-27       Impact factor: 6.244

8.  A step ahead toward precision medicine for chronic lymphocytic leukemia.

Authors:  Andrea Patriarca; Gianluca Gaidano
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

9.  <i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation

Authors:  Federico Pozzo; Tamara Bittolo; Erika Tissino; Filippo Vit; Elena Vendramini; Luca Laurenti; Giovanni D'Arena; Jacopo Olivieri; Gabriele Pozzato; Francesco Zaja; Annalisa Chiarenza; Francesco Di Raimondo; Antonella Zucchetto; Riccardo Bomben; Francesca Maria Rossi; Giovanni Del Poeta; Michele Dal Bo; Valter Gattei
Journal:  Haematologica       Date:  2021-12-01       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.